Abstract

Rosacea patients show facial hypersensitivity to stimulus factors (such as heat and capsaicin); however, the underlying mechanism of this hyperresponsiveness remains poorly defined. Here, we show capsaicin stimulation in mice induces exacerbated rosacea-like dermatitis but has no apparent effect on normal skin. Nociceptor ablation substantially reduces the hyperresponsiveness of rosacea-like dermatitis. Subsequently, we find that γδ T cells express Ramp1, the receptor of the neuropeptide CGRP, and are in close contact with these nociceptors in the skin. γδ T cells are significantly increased in rosacea skin lesions and can be further recruited and activated by neuron-secreted CGRP. Rosacea-like dermatitis is reduced in T cell receptor δ-deficient (Tcrd−/−) mice, and the nociceptor-mediated aggravation of rosacea-like dermatitis is also reduced in these mice. In vitro experiments show that CGRP induces IL17A secretion from γδ T cells by regulating inflammation-related and metabolism-related pathways. Finally, rimegepant, a CGRP receptor antagonist, shows efficacy in the treatment of rosacea-like dermatitis. In conclusion, our findings demonstrate a neuron-CGRP-γδT cell axis that contributes to the hyperresponsiveness of rosacea, thereby showing that targeting CGRP is a potentially effective therapeutic strategy for rosacea.

Rosacea is a common chronic inflammatory cutaneous disease that is exacerbated by heat and capsaicin pepper stimulation. Here the authors use a mouse model of rosacea and demonstrate functions of nociceptors, response to the neuropeptide CGRP and involvement of γδ T cells in the aggravation of rosacea like-disease.

Details

Title
High-sensitive sensory neurons exacerbate rosacea-like dermatitis in mice by activating γδ T cells directly
Author
Zhang, Yiya 1   VIAFID ORCID Logo  ; Li, Tao 2 ; Zhao, Han 2 ; Xiao, Xin 2 ; Hu, Ximin 2 ; Wang, Ben 2 ; Huang, Yingxue 2 ; Yin, Zhinan 3   VIAFID ORCID Logo  ; Zhong, Yun 2 ; Li, Yangfan 4 ; Li, Ji 1   VIAFID ORCID Logo 

 Central South University, Department of Dermatology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, Hunan key laboratory of aging biology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, P.R. China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Central South University, Department of Dermatology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, Hunan key laboratory of aging biology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Jinan University, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People’s Hospital Affiliated with Jinan University, Zhuhai, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548); Jinan University, The Biomedical Translational Research Institute, Health Science Center (School of Medicine), Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548) 
 Central South University, Department of Dermatology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, Hunan key laboratory of aging biology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); The First Affiliated Hospital of Zhengzhou University, Department of Dermatology, Zhengzhou, China (GRID:grid.412633.1) 
Pages
7265
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3096460548
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.